HomeFile

File

Use of Plaque Modifying Devices in Calcified Left Main Lesions

Treating severely calcified left main coronary artery (LMCA) lesions is one of the greatest challenges in interventional...

Conduction Disorders Before TAVR: What Is Their Impact?

Transcatheter aortic valve replacement (TAVR) has become an established treatment for severe aortic stenosis and is now...

Balloon-Expandable Myval Valve Four-Year Outcomes

The expanding indication of transcatheter aortic valve replacement (TAVR) to younger patients or those at lower surgical...

Statins and Small Abdominal Aortic Aneurysms: Unexpected Aid?

Courtesy of Dr. Juan Manuel Pérez. Abdominal aortic aneurysms (AAA) entail high morbimortality in case of rupture, and...

Coronary Events Following TAVI: A Registry

Between 30 and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary artery disease (CAD)....

Transcatheter Treatment with EVOQUE: First Real-World Results

Severe tricuspid regurgitation (TR) has historically been underestimated due to its poor prognosis and the limited benefit...

Renal Denervation and SPYRAL HTN-ON MED Two-Year Outcomes

High blood pressure (BP) continues to be one of the leading preventable causes of cardiovascular events worldwide....

Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

Physiology guided revascularization has been shown to improve clinical outcomes vs. conventional angiography. However, after percutaneous coronary...